U.S. Biotech Industry Analysis
UpdatedMay 23, 2024
DataAggregated Company Financials
Companies572
- 7D0.07%
- 3M-2.0%
- 1Y6.9%
- YTD1.2%
Over the last 7 days, the Biotech industry has remained flat, although notably Moderna gained 27%. The past year has been better, since the industry has gained 6.9% in that time. As for the next few years, earnings are expected to grow by 25% per annum.
Industry Valuation and Performance
Has the U.S. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 23 May 2024 | US$1.1t | US$164.6b | -US$26,731,616,038.85 | 24.6x | -42.6x | 6.9x |
| Sat, 20 Apr 2024 | US$1.1t | US$164.2b | -US$23,337,120,518.73 | 20.4x | -45.9x | 6.5x |
| Mon, 18 Mar 2024 | US$1.2t | US$167.4b | -US$22,071,849,383.64 | 13.9x | -53.2x | 7x |
| Wed, 14 Feb 2024 | US$1.1t | US$168.9b | -US$20,817,013,760.70 | 18x | -54.6x | 6.7x |
| Fri, 12 Jan 2024 | US$1.4t | US$204.8b | -US$22,495,274,678.00 | 19.2x | -64.1x | 7x |
| Sun, 10 Dec 2023 | US$1.3t | US$204.6b | -US$22,091,414,218.00 | 18.7x | -58.3x | 6.3x |
| Tue, 07 Nov 2023 | US$1.2t | US$203.9b | -US$22,185,418,652.00 | 18.9x | -56x | 6.1x |
| Thu, 05 Oct 2023 | US$1.2t | US$207.3b | -US$13,076,809,948.00 | 16.7x | -94.9x | 6x |
| Sat, 02 Sep 2023 | US$1.3t | US$207.6b | -US$12,424,624,459.00 | 18.4x | -104.2x | 6.2x |
| Mon, 31 Jul 2023 | US$1.2t | US$186.0b | -US$15,168,211,533.00 | 14.7x | -76.1x | 6.2x |
| Wed, 28 Jun 2023 | US$1.1t | US$186.3b | -US$16,125,527,732.00 | 13.5x | -69.1x | 6x |
| Fri, 26 May 2023 | US$1.1t | US$185.9b | -US$15,950,003,280.00 | 11.5x | -71.8x | 6.2x |
| Sun, 23 Apr 2023 | US$1.2t | US$198.4b | -US$3,214,788,122.00 | 13.9x | -370.1x | 6x |
| Tue, 21 Mar 2023 | US$1.1t | US$199.3b | -US$3,748,498,766.00 | 12.7x | -301.2x | 5.7x |
| Thu, 16 Feb 2023 | US$1.2t | US$202.5b | US$17.8m | 16.3x | 64811.8x | 5.7x |
| Sat, 14 Jan 2023 | US$1.2t | US$203.7b | US$1.8b | 14.5x | 670.8x | 5.8x |
| Mon, 12 Dec 2022 | US$1.1t | US$202.7b | US$1.4b | 14.6x | 811.7x | 5.6x |
| Wed, 09 Nov 2022 | US$1.1t | US$204.5b | US$3.9b | 14.4x | 280.2x | 5.3x |
| Fri, 07 Oct 2022 | US$1.1t | US$206.2b | US$5.5b | 15.1x | 193.6x | 5.1x |
| Sun, 04 Sep 2022 | US$1.0t | US$206.4b | US$6.2b | 14.6x | 167.9x | 5x |
| Tue, 02 Aug 2022 | US$1.0t | US$212.2b | US$11.4b | 15.4x | 90.7x | 4.9x |
| Thu, 30 Jun 2022 | US$1.0t | US$212.2b | US$11.0b | 15.7x | 94.5x | 4.9x |
| Sat, 28 May 2022 | US$1.0t | US$212.7b | US$11.1b | 16.1x | 92.8x | 4.8x |
| Mon, 25 Apr 2022 | US$1.2t | US$226.6b | US$14.7b | 17.8x | 81.5x | 5.3x |
| Wed, 23 Mar 2022 | US$1.3t | US$221.9b | US$10.6b | 19.8x | 122.3x | 5.9x |
| Fri, 18 Feb 2022 | US$1.2t | US$216.4b | US$5.7b | 21.9x | 214.8x | 5.7x |
| Sun, 16 Jan 2022 | US$1.3t | US$212.1b | US$2.5b | 24.4x | 527.3x | 6.2x |
| Tue, 14 Dec 2021 | US$1.4t | US$211.9b | US$3.1b | 25.2x | 449.8x | 6.7x |
| Thu, 11 Nov 2021 | US$1.5t | US$204.8b | -US$58,717,099.00 | 25.4x | -24760.2x | 7.1x |
| Sat, 09 Oct 2021 | US$1.5t | US$196.3b | -US$2,607,286,814.00 | 23.3x | -558.7x | 7.4x |
| Mon, 06 Sep 2021 | US$1.6t | US$196.4b | -US$2,275,254,373.56 | 22.4x | -705.5x | 8.2x |
| Wed, 04 Aug 2021 | US$1.6t | US$197.0b | -US$1,413,253,338.58 | 22.6x | -1110.5x | 8x |
Price to Earnings Ratio
-120.4x
Current Industry PE
- Investors are optimistic on the American Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 6.2x is lower than the industry's current PS ratio of 6.9x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the U.S. Healthcare industry?
| US Market | -0.19% | |
| Healthcare | -0.012% | |
| Biotech | 0.074% | |
| Biotech | 0.074% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MRNA Moderna | US$163.33 | 26.6% +US$13.1b | 24.1% | PS12.1x | |
| VRTX Vertex Pharmaceuticals | US$447.53 | 2.3% +US$2.6b | 34.1% | PE28.7x | |
| BNTX BioNTech | US$102.30 | 11.0% +US$2.5b | -7.9% | PE201.9x | |
| SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
| GRPH Graphite Bio | US$22.26 | 539.7% +US$1.1b | 861.6% | PB7.1x |
